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Abstract
Tens of thousands of splice isoforms of proteins have been catalogued as predicted sequences from 
transcripts in humans and other species. Relatively few have been characterized biochemically or 
structurally. With the extensive development of protein bioinformatics, the characterization and 
modeling of isoform features, isoform functions, and isoform-level networks have advanced 
notably. Here we present applications of the I-TASSER family of algorithms for folding and 
functional predictions and the IsoFunc, MIsoMine, and Hisonet data resources for isoform-level 
analyses of network and pathway-based functional predictions and protein-protein interactions. 
Hopefully, predictions and insights from protein bioinformatics will stimulate many experimental 
validation studies.
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1 Introduction
One of the most remarkable developments in biological evolution is the emergence in 
multicellular organisms of gene structures with exons and introns. An elaborate splicing 
machinery in cells processes heterogeneous nuclear RNAs and generates several different 
mRNA transcripts from individual genes that can be translated into protein products. Just 
describing gene or protein expression as “upregulated” or “downregulated” ignores the fact 
that these transcripts and proteins are mixtures. These splice variants can and often do have 
dramatically different functions; when the proteins fold similarly and compete for target 
sites, they may, in fact, have opposing actions, such as proapoptotic and antiapoptotic 
activities [1].
Alternative splicing generates protein diversity without increasing genome size. This 
phenomenon seems to explain how humans can “get by” with only 20,000 protein-coding 
genes, whereas there were predictions of 50,000 to 100,000 or more protein-coding genes 
when the Human Genome Project was launched. The splice variants cannot be identified in 
genome sequences, but the splicing can be mapped to the gene exon/intron structures. There 
are multiple kinds of splicing events, including alternative 5 ′ or 3′ start sites, mutually 
exclusive exons (exon swaps), intron retention, alternative promoters, and alternative 
polyadenylation. There are examples of every kind of splicing in cancers, for example, and 
complex combinations of splice isoforms are well described in the nervous system. Ensembl, 
HHS Public Access
Author manuscript
Methods Mol Biol. Author manuscript; available in PMC 2018 May 24.
Published in final edited form as:
Methods Mol Biol. 2017 ; 1558: 415–436. doi:10.1007/978-1-4939-6783-4_20.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
UniProt, neXtProt, RefSeq, and ECgene are databases with extensive information about 
protein splice variants.
2 Materials
Depending on the biological or clinical question being investigated, either primary 
experimental data or publicly available datasets for protein and transcript isoforms from 
appropriate specimens may be utilized for annotation and characterization of splice 
isoforms. For example, we have characterized splice isoforms of Her2/ERBB2+ breast 
cancers from humans and in mouse models [2, 3].
1. Use the current version of UniProt (e.g., release 2015/03) at http://
www.uniprot.org to obtain a reliable, high-quality set of protein isoforms which 
are consistently annotated both in Ensembl (version 75) at http://
wwwensemblorgHomo_sapiens/Info/Index and in NCBI RefSeq (e.g., release 
70) at http://www.ncbi.nlm.nih.gov/refseq/.
Note that the annotation on splice isoforms varies from database to database and 
version to version. In Ensembl, information on protein-coding transcripts for a 
gene is updated or changed whenever the database version is changed. RefSeq is 
generally less inclusive than Ensembl.
The identification of a “canonical isoform” often defaults to the longest product 
(protein sequence). UniProt curators choose a canonical variant from among 
several protein isoforms encoded by one gene using some mixture of the 
following criteria: highest expressed (varies by tissue and conditions); most 
conserved across species; the amino acid sequence that allows the clearest 
description of domains, isoforms, polymorphisms, and post-translational 
modifications; or, finally, the longest sequence. The other sequences are called 
“noncanonical” isoforms: see http://www.uniprot.org/help/canonicalandisoforms. 
As described below, we propose a method to identify the “most highly connected 
isoform” and consider the highest connected isoform (HCI) the canonical form.
Generally, the functional annotation of genes is based on their widely studied 
canonical protein or, more crudely, on the mixture of unrecognized isoforms. 
There is only very limited experimental evidence or computational annotation of 
functions of noncanonical protein isoforms. Gene ontology (GO) and Kyoto 
encyclopedia of genes and genomes (KEGG) are widely used; we recommend 
also using GeneCards for gene-level annotations (http://www.genecards.org/).
2. RNA-Seq provides far more precise measurement of levels of expression of 
transcripts and their isoforms than microarray analyses do. Available datasets can 
be downloaded from the NCBI Short Read Archive (http://
www.ncbi.nomlnih.gov/sra). Often there are biological replicates available.
Analyze the RNA-Seq data using Sailfish [4], an alignment-free algorithm 
(unlike Tophat/Cufflinks) for estimation of the isoform abundances. Sailfish 
builds a unique index of all k-mers (short and consecutive sequences containing 
k nucleic acids), counts the occurrences of the k-mers in the RNA-Seq 
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fragments, and quantitates the transcripts by the number of occurrences of the k-
mers through an EM algorithm. The index file for the Sailfish quantitation 
process can be generated from Ensembl cDNA file (GRCh38 version).
Use the R package edgeR to quantitate differential expression of transcript 
isoforms between two tissues or tumor types being compared. This method uses 
an over-dispersed Poisson model to account for biological and technical 
variability. Bonferroni correction of p values for multiple hypothesis testing can 
be performed with the p.adjust function in stats, R package (http://stat.ethz.ch/R-
manual/R-patched/library/ stats/html/p.adjust.html). Use the Sailfish estimates of 
read counts for each transcript isoform in calculations of differential expression.
3 Methods
3.1 Inferring Structure and Function of Protein Isoforms Using Structural Bioinformatics 
Tools
We developed an integrated computational approach with tools for 3D protein structure 
prediction and structure-based protein function annotation, which can be used for inferring 
potential folding and functions of the noncanonical splice proteins compared with those of 
the canonical proteins. As examples, we first applied this approach to examining the 
function and folding stability of pyruvate kinase M2 isoforms, whose 3D structures were 
known, and three cancer-related isoform pairs, Bcl-x, caspase 3, and odd-skipped related 2, 
which were reported to have opposite functions, but lacked experimentally derived structures 
[5].
3.1.1 Protein 3D Structure Prediction—We developed and recommend two methods, 
I-TASSER [6–11] and QUARK [12–14] for template-based and ab initio protein structure 
predictions, respectively (Fig. 1).
For additional comments about the I-TASSER family of tools and alternative methods, see 
Subheading 4.
I-TASSER pipeline for template-based structure prediction: The pipeline of I-TASSER 
is presented in Fig. 1a. The classic I-TASSER is depicted in the left-bottom panel of Fig. 1a, 
which consists of three steps:
1. Thread the query sequence through the PDB library by a locally installed meta-
threading-server (LOMETS) method [15] to identify structure templates. 
Because LOMETS combines multiple threading programs based on different but 
complementary alignment algorithms, the templates often have improved 
structural coverage and alignment accuracy compared to individual threading 
algorithms.
2. Construct full-length model by reassembling the continuous segments excised 
from the templates in the threading-aligned regions using iterative replica-
exchange Monte Carlo (REMC) simulations, where the structure in the 
threading-unaligned regions is built by an on-lattice ab initio modeling 
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procedure. The REMC simulations are guided by a highly optimized knowledge-
based force field that consists of generic backbone contact and correlation 
interactions, hydrogen bonding, and threading template-based restraints [11, 16].
3. Select the lowest free energy models by the clustering of all structure decoys as 
generated by the REMC simulations [17, 18]; the atomic models are then refined 
by REMO via the optimization of the hydrogen-bonding networks [19].
In recent developments, we proposed three methods to improve the accuracy of I-TASSER 
for distant homology modeling. These new developments are depicted in the upper-right 
panel of Fig. 1a, which was proved efficient in improving the modeling accuracy for proteins 
that lack close homologous templates [20]. These include:
1. Extended SVMSEQ [21] to generate multiple-scale residue contacts to guide the 
long-range I-TASSER structure assembly [22]
2. Developed SEGMER [23] to detect super-secondary structural motifs by 
segmental threading which improve spatial restraints of medium-range I-
TASSER simulations
3. Applied FG-MD [24] to refine I-TASSER models at the atomic level based on 
fragment-guided molecular dynamic simulations, where the fragments from the 
PDB are shown to be able to improve the funnel of landscape of the physics-
based force field.
QUARK pipeline for ab initio protein structure folding: Because the accuracy of I-
TASSER predictions often relies on the existence of PDB templates and cannot be used to 
model proteins with new folds, we developed QUARK for ab initio protein structure 
prediction (Fig. 1b), [12, 25], which consists of three steps:
1. Select 200 short fragments at each position of the target sequence, each with 1–
20 residues, from unrelated proteins by gapless matches.
2. Use the selected fragments to assemble full-length models by REMC 
simulations, under a composite physics- and knowledge- based potential that 
consists of H-bond, van der Waals, solvation, Coulomb, backbone torsion, bond 
length and angle, and statistical strand and helix packing interactions [12]. 
Meanwhile, non-covalent contact and distance profiles are derived from the 
short-range fragments by consistency analysis and used to accommodate long-
range packing simulations [25].
3. Select final models by SPICKER clustering program, and then refine the atomic 
models by ModRefiner [26] through a two- step atomic-level minimization to 
improve H-bond networks and physical realism.
Test of structure prediction methods in blind CASP experiments: I-TASSER and 
QUARK have been tested in both benchmark [6, 7, 12, 13, 27] and blind experiments [8, 9, 
10, 28–30]. For the blind test, community-wide CASP experiments have been organized 
every two years since 1994 to examine the state of the art of structure prediction methods 
(http://predictioncenter.org) [31, 32]. Structure predictions of a set of >100 protein targets 
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are made before the experimental structures are released, and the modeling results by 
predictors are assessed by independent scientists. The CASP experiments have attracted 
hundreds of predictors from the community in the last two decades. I-TASSER was tested 
(as “Zhang-server”) in the seventh–eleventh CASP competitions in 2006–2014, and 
QUARK participated in the ninth and tenth CASPs. I-TASSER and QUARK have 
consistently ranked in the top two positions in the automated server section for generating 
the most accurate protein structure predictions [29, 30, 33–35]. These results demonstrate 
the advantage of these pipelines over other state-of-the-art methods for high-resolution 
protein structure predictions.
3.1.2 Structure-Based Function Annotations—To annotate the biological functions 
of proteins, we first developed a high-quality protein function database, BioLiP [36], semi-
manually curated from databases and PubMed literature. Two complementary approaches, 
COFACTOR [37, 38] and COACH [39], were then proposed to predict the protein functions 
by structurally matching the prediction structure models with the known proteins in BioLiP.
Development of protein functional databases: Many structure-based protein function 
analyses and prediction studies use known proteins solved in the PDB [40] as templates to 
infer biological functions of unknown proteins. However, numerous proteins in the PDB 
contain redundant entries and/or misordered residues and functions. In particular, many 
proteins were solved using artificial molecules as additives to facilitate the structural 
determination experiments. These ligands do not necessarily represent biologically relevant 
binding. Therefore, it is essential to develop cleaned protein libraries with biological 
functions carefully validated. We proposed a hierarchical procedure, which consists of three 
steps of computational filtering and manual literature validation for assessing the biological 
relevance of the annotated protein functions.
1. Download 3D structure for each entry in the PDB, with the modified residues 
(i.e., residues modified post-translationally, enzymatically, or by design) 
translated to their precursor standard residues based on the MODRES record. To 
exclude crystallization neighbors, the biological unit files rather than the 
asymmetric unit files are used for evaluating the ligand-protein contacts.
2. Extract ligands, which are defined as small molecules, from the PDB file. Three 
types of ligand molecules are collected in the BioLiP database, the molecules 
from the HETATM records (excluding water and modified residues), small DNA/
RNA, and peptides with less than 30 residues. If the closest inter-atomic distance 
between two HET group ligands is smaller than 2 Å, the two ligands are merged 
as a single ligand and are regarded as a k-mer ligand.
3. Submit each ligand molecule to a composite automated and manual procedure to 
decide its biological relevance. If the ligand molecule is evaluated as biologically 
relevant, its interaction with the receptor (i.e., binding site residues in the 
receptor) is deposited into the BioLiP database. Additionally, the ligand-binding 
affinity, catalytic site residues, EC numbers, GO terms, and cross-links to the 
PDB, UniProt, PDBsum, PDBe, and PubMed databases are also collected and 
deposited into BioLiP.
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BioLiP is updated weekly and is freely available for the community at http://
zhanglab.ccmb.med.umich.edu/BioLiP. The current release of BioLiP contains 344,990 
entries constructed from 72,005 unique PDB proteins, in which 40,078 entries are for DNA/
RNA-protein interactions, 15,648 for peptide-protein interactions, 94,907 for metal ion-
protein interactions, and 184,357 for regular small molecule-protein interactions. There are 
in total 23,492 entries with binding affinity data collected from Binding MOAD [41], 
PDBbind-CN [42], and BindingDB [43] databases and from a manual survey of the 
literature. It also contains proteins of known enzyme commission (EC) [44] and gene 
ontology (GO) [45]. Currently, the EC domain of BioLiP involves 7674 protein chains with 
203 unique first three-digit and 1900 unique four-digit enzyme commission numbers. The 
GO domain contains 26,004 chains/domains associated with 11,686 unique gene ontology 
terms. These data provide important resources for function annotation studies.
COFACTOR method for EC, GO, and ligand-binding predictions: COFACTOR is a 
template-based approach developed for structure-based function annotation [37, 38].
1. Identify functional templates by global and local structural matches of the target 
proteins with the known proteins in the BioLiP [36]. The target structures can be 
either from experimental determination or computational structure prediction.
2. Infer functional insights, including ligand-binding sites, enzyme commission 
number, and gene ontology terms, from the highest scoring function templates.
COFACTOR was tested in the function prediction section of the ninth CASP experiment, 
where COFACTOR (as “I- TASSER_ FUNCTION” in the server section and “ZHANG” in 
the human section) was ranked in the first two positions [46].
COACH protocol for ligand-binding prediction: Because individual methods can only 
generate predictions for specific protein targets, we proposed a new protocol, COACH, 
which aims to extend the coverage of function predictions by combining results from 
multiple methods (Fig. 2) [39]. The pipeline consists of two steps:
1. Use two complementary algorithms TM-SITE and S-SITE to derive functional 
templates from BioLiP library. TM-SITE was designed to recognize functional 
templates by binding-specific substructure comparison combined with 
biochemical feature alignment of binding pockets. S-SITE uses protein sequence 
profile collected by PSI-BLAST that is then searched through BioLiP.
2. Combine multiple predictions by TM-SITE and S-SITE, together with three 
other predictors (COFACTOR [38], FINDSITE [47], and Concavity [48]), to 
derive consensus function annotations using support vector machine (Fig. 2).
The COACH protocol was examined in the recent community-wide COMEO experiment 
designed to test ligand-binding predictions using prereleased PDB sequences as a continuous 
base [49]. COACH was consistently ranked as the best method in the last 22 individual 
datasets with its average AUC score, the area under the curve of the true positive rate versus 
false positive rate plot, 22.5 % higher than the second best method [49].
Li et al. Page 6
Methods Mol Biol. Author manuscript; available in PMC 2018 May 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
3.1.3 Structure-Based Function Annotations of Alternative Splice Proteins 
Expressed in Her2/Neu-Induced Breast Cancers
Identification of splice variant peptides in tumor tissue of mice with her2/neu-amplified 
breast cancer: We analyzed tumor and normal mammary tissue LC-MS/MS datasets from 
the Chodosh mouse model of Her2/neu-driven breast cancer, which accounts for 15–20 % of 
breast cancers in humans [50]. A total of 608 distinct alternative splice variants, 540 known 
and 68 novel, were identified [3]. There were 216 more from the tumor lysate than from the 
normal sample (505 vs. 289), probably reflecting greater cellularity and higher expression 
per cell. We chose 32 of the 45 novel proteins expressed only in tumor specimens for 
confirmation with qRT-PCR; all were confirmed except for one primer which did not work, 
and 29 of 31 showed increased mRNA expression. Of the 15 biomarker candidates that 
Whiteaker et al. [50] confirmed as over-expressed in tumor lysates with MRM-MS, we 
found that 10 had splice variants in our analysis, although we had no information on the 
functional activities of the different isoforms of these or any other proteins from proteomic 
analyses.
Among the 68 novel proteins, we demonstrated variants resulting from new translation start 
sites, new splice sites, extension or shortening of exons, deletion or swap of exons, retention 
of introns, and translation in an alternative reading frame. Our annotations revealed multiple 
variants with potential significant functional motifs, including two relating to BRCA1 
through binding to its BRCT domain. The peptide sequence 
“FSRAEAEGPGQACPPRPFPC” is in the second intronic region of leucine zipper-
containing LF (Rogdi) gene. Using Splice Site Prediction by Neural Network from the 
Berkeley Drosophila Genome Project (http://w.fruitfly.org/ seq_tools/splice.html), we found 
a predicted donor splice site “gactgaggtgaggtg” where the novel peptide was identified as 
coding sequence with a splice site prediction score of 0.93. Functional motifs identified in 
expressed intronic sequences include LIG_BRCT_BRCA1_1, a phosphopeptide motif which 
interacts directly with the carboxy-terminal domain of BRCA1. The peptide 
“GSGLVPTLGRGAETPVSGAGATRGLSR” aligned to the first intronic region of 
transcription factor sox7; the very same LIG-BRCT_BRCA1_1 motif was found in this 
intronic region.
Structure modeling-based analysis on alternative splice proteins in Her2/neu-induced 
breast cancers: Experimentally determined structures of protein splice isoforms remain 
rare; in fact, there were only seven full-length pairs of such isoforms in the enormous 
Protein Data Bank (PDB) and the Alternative Splicing and Transcript Diversity (ASTD) 
database as of 2011 [5]. Homology modeling methods are poor at predicting atomic-level 
structural differences because of the high sequence identity between the isoforms. We 
exploited the bioinformatics tools [6, 11, 38, 39] described above (Subheading 3.1) to 
analyze the folding, structural conformation, and likely functional consequences of 
alternative splicing of proteins identified in the Her2/neu-induced breast cancer model [5]. 
The procedure of the application consists of three steps:
1. Based on the I-TASSER modeling, we have demonstrated that attributes in ab 
initio structural assembly and template refinement can partially differentiate 
atomic details of splice protein variant pairs [5]. The structure modeling 
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approach was bench-marked on the seven pairs of protein splice isoforms with 
solved structures in PDB, which resulted in structural models with an average 
RMSD = 1.72 Å to the native, after excluding all homologous templates to the 
targets. Some of the structural variations in the isoform pairs were due to exon 
swapping. Even alternative splice variants whose structures are very similar may 
have functional differences due to the absence of a functionally critical residue or 
altered post-translational modifications of residues in the swapped exon. For 
example, in the case of acid phosphatase (acp1) variants, the Mg2+-binding site is 
missing in the 1xwwA variant.
2. We used the strategy to model three cancer-related variant pairs reported to have 
opposite functions, but lacking experimentally derived structures: Bcl-x, caspase 
3, and odd-skipped related 2. In each isoform pair, we observed structural 
differences in regions where the presence or absence of a motif can directly 
influence the distinctive functions of the variants. For example, an additional 63 
amino acids (AA 129–191) create an extra domain in the core structure of bclx-L 
(233 AA) compared with bclx-S (170 AA); the shorter variant is missing the two 
Bcl-2 family motifs BH1 and BH2, while the longer variant contains all four 
Bcl-2 homology motifs (BH1–4). This difference results in a completely 
different topology and function; bclx-L is antiapoptotic, while bclx-S is 
proapoptotic.
3. We applied I-TASSER to five splice-variant pairs overexpressed in the mouse 
Her2/neu mammary tumor: annexin 6, calumenin, cell division cycle 42 (cdc42), 
polypyrimidine tract-binding protein 1 (ptbp1), and tax1-binding protein 3 
(tax1bp3). These pairs were chosen based on the following five criteria: 
differential expression, annotated as a known protein in Ensembl, at least 75 % 
sequence identity with the canonical protein, known homologous variants of the 
protein pair in Homo sapiens, and an I-TASSER confidence score (C-score) for 
both variants >−1.5 to ensure the quality of structure prediction.
Despite the high sequence identity between the variant pairs (99, 92, 95, 95, and 79 %, 
respectively), structural differences were revealed in biologically important regions of these 
protein pairs. For example, the only difference between anxa6-001 and anxa6-002 at the 
sequence level is the presence of six residues in anxa6-001 (VAAEIL, AA 525–530) that are 
missing in anxa6-002. The global topology of the I-TASSER models of the two isoforms is 
almost identical, with RMSD = 0.38 Å and TM-score = 0.99. However, there is an obvious 
local structural change in the region due to the absence of “VAAEIL” residues (AA 525−530 
in anxa6-001), as identified by the structural alignment algorithm, TM-align [51]. As 
reported, these six residues are in the end of a helical region (blue-colored in the original 
figure) which is followed by a loop. Because of the absence of the six residues, the loop is 
smaller in the shorter variant. The nearby proline-directed kinase phos-phorylation ([ST]P) 
site followed by a serine phosphorylation site moves from 535–537 to 529–531, inside the 
helix region in anxa6-002, where phosphorylation is less probable than for anxa6-001.
The I-TASSER models in Fig. 3 show that the threonine and proline residues are buried by 
other atoms in the anxa6-002 variant, whereas the hydroxyl group of serine (S531 in 
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anxa6-002) seems quite accessible for phosphorylation (see inset of Fig. 3b). In order to 
search for phosphopeptides from the spliced region of anxa6, we performed a fresh analysis 
of the mass spectrometric data with our custom database using X! Tandem, specifying 
phosphorylation on serine or threonine (phospho(S) and phospho(T)) as potential residue 
modifications. Because phosphorylation is usually present at low stoichiometry and our 
dataset was not enriched for phosphopeptides, it was striking that we identified a spectrum 
from the normal sample that matched to the peptide “DQAQED 
AQVAAEILEIADTPSGDKTSLETR” with 3281.5 daltons as the calculated peptide mass 
plus a proton (mh). The unmodified mh of this peptide is 3201.5 daltons; the additional 80 
daltons can be accounted for precisely by phosphorylation of either the threonine or serine 
residue in the peptide. We did not find such a phospho-peptide from the tumor sample. 
However, we did find multiple high-quality spectra from the tumor sample that identified the 
sequence “DQAQEDAQEIADTPSGDKTSLETR,” the unique peptide that matches the 
anxa6 short variant (with residues “VAAEIL” missing). None of these spectra revealed 
modification by phosphorylation. Even though only a single spectrum identified the 
phosphopeptide from the unique region of the long anxa6 variant in the X! Tandem search, 
these observations are consistent with our functional inference from the structural 
comparison of the anxa6 variants [5] that the longer anxa-001 variant is more prone to 
undergo phosphorylation at Thr-535 or Ser-537 than in the anxa-002 variant at the Thr-529 
or Ser-531 sites. Post-translational phosphorylation of anxa6 has been reported to be 
associated with cell growth in 3T3 fibroblasts and human T-lymphoblasts [52]; we 
previously predicted that the critical phosphorylation may occur at Thr-535 and/or Ser-537 
in the loop region. We have now strikingly refined this prediction, which we hope 
experimentalists will test.
3.2 Methods for Annotation of Protein Isoform Structure and Predicted Functions, Using 
Support Vector Machine Multiple-Instance Learning to Predict Functions of Isoforms and 
Isoform-Level Networks
The prediction of isoform functions and networks can be formulated as a problem that can 
be addressed by multiple-instance learning (MIL) algorithms [53]. MIL works mainly in 
three steps (Fig. 4):
1. Initialization: label all isoforms in positive genes as Class 1 and all isoforms in 
negative genes as 0.
2. Model building: build a classifier using a given method such as support vector 
machines and Bayesian networks followed by using this classifier to score all 
isoforms.
3. Witness updating: reselect the highest scored isoform from positive genes as 
“witness,” and label them as Class 1. All other isoforms are labeled as Class 0. If 
results are not converged, go to step 2. Otherwise, the converged model is stored 
for predicting isoform functions.
3.2.1 Genome-Wide Isoform Functions and Networks in the Mouse—Eksi et al. 
performed the first genome-wide isoform function predictions using the MIL algorithm for 
the mouse [53]. The method is described in the following steps:
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1. Collect isoform feature data. A total of 811 RNA-Seq experiments (samples) 
were downloaded from the NCBI Sequence Read Archive (SRA) database 
(http://www.ncbi.nlm.nih.gov/sra), followed by estimating isoform expression 
using the TopHat and Cufflinks suites (v2.0.051). Quality control was conducted 
[53], and 365 samples were kept for subsequent analysis. All isoform expression 
from these 365 samples was collected into a data matrix.
2. Select “gold standard” of gene functions. Biological process terms in GO were 
used as “gold standard” for functional annotation.
3. Learn a support vector machine (SVM) model from the above collected data 
using the MIL algorithm (Fig. 4).
4. Use the learned SVM model to predict functions for all mouse isoforms.
5. Build a web server to make isoform functions publicly available and searchable 
(http://guanlab.ccmb.med.umich.edu/isoPred).
Taking Anxa6 (Annexin A6) as an example, the steps for querying the functions of its 
isoforms are described below (also shown in Fig. 5).
1. Go to website http://guanlab.ccmb.med.umich.edu/isoPred, type in “Anxa6” in 
the input box, and click the “Search” button (step 1, Fig. 5).
2. Users will be guided to http://guanlab.ccmb.med.umich. edu/isoPred/
search_result.php. Locate “Anxa6” in the form on this page, and click it (step 2, 
Fig. 5).
3. Users will be guided to http://guanlab.ccmb.med.umich.edu/isoPred/
gene_result.php?gene=Anxa6. On this page, see function predictions for each 
isoform presented in the table (step 3, Fig. 5).
Further, Li et al. constructed a genome-wide functional relationship network for the mouse 
[54, 55] with the following steps:
1. Collect isoform-pair feature data: RNA-Seq, exon array, pseudo-amino acid 
composition (pseudoAAC), and protein-docking data. For RNA-Seq and exon 
array, isoform expression was estimated followed by calculating isoform 
correlation as feature data. Correlation was also calculated between isoforms 
using their pseudoAAC profile. Protein-docking itself is an isoform-pair feature.
2. Construct “gold standard” of functionally related gene pairs. GO biological 
processes and KEGG and BioCyc pathways were used to construct a “gold 
standard” of functionally related gene pairs. Genes annotated to the same 
biological process or GO term are assumed to have a functional relationship.
3. Learn a model using MIL with Bayesian network as the base learner.
4. Use the learned model to make genome-wide predictions of functional 
relationship between any two isoforms.
5. Build a web server to allow users to search isoform networks. It is publicly 
available at http://guanlab.ccmb.med.umich. edu/isoformnetwork.
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Users can go to this server, input their gene(s) of interest, click the “Search” button, and see 
isoform networks along with GO enrichment results.
Based on the mouse isoform network, Li et al. catalogued the highest connected isoforms 
(HCIs) as a predicted “canonical isoform” using the following approach [55].
1. Calculate an average functional relationship (AFR) score for each isoform of 
multi-isoform genes.
2. For each multi-isoform gene, choose the isoform with the highest AFR score as 
HCI. The remaining isoforms are considered as NCI (non-highest connected 
isoforms).
3. Use independent RNA-Seq and proteomic data to investigate the expression of 
HCI at both transcript and protein levels.
4. Identify a set of genes whose HCIs are most expressed at transcript level and are 
also expressed at protein level.
Further, the MIsoMine database was developed to provide an integrated platform for 
analyzing isoform expression, functions, and networks for the mouse [56]. Users can go to 
the website (http://guanlab.ccmb.med.umich.edu/misomine/) to perform isoform-level 
analyses.
3.2.2 Genome-Wide Isoform Functions and Networks in the Human—Panwar et 
al. predicted functions for splice isoforms in humans [57]. The approach mainly consists of 
the following steps:
1. Download the human RNA-Seq data from the ENCODE study [58]; 127 samples 
were used. The TopHat and Cufflinks suites were used to estimate isoform 
expression in terms of FPKM [59] using the Ensembl gene annotation 
(version74, available at http://www.ensembl.org/).
2. Use gene ontology biological processes to construct “gold standard” functional 
annotations.
3. Build an SVM model using the MIL algorithm, and use the model to predict the 
functions of all human isoforms.
4. Build a web server to store all the predictions and to make the predictions 
searchable (http://guanlab.ccmb.med.umich.edu/isofunc/).
In addition to isoform functions, Li et al. built a genome-wide function relationship network 
at the isoform level for the human [60], an effort from the chromosome 17 Human Proteome 
Project [61]. The pipeline is described below:
1. Collect four types of isoform-level feature data, including RNA-Seq expression, 
pseudo-amino acid composition, protein-docking score, and conserved domains.
2. Construct a “gold standard” of functionally related gene pairs using GO 
biological processes and KEGG pathways.
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3. Build a Bayesian network classifier using the MIL algorithm, and use the model 
to make genome-wide predictions of function relationships between isoforms.
4. Build a web server to store the human isoform network (http://
guanlab.ccmb.med.umich.edu/hisonet). Users are able to query isoform networks 
of their genes of interest.
In addition, using the same method described in Subheading 3.2.1, Li et al. catalogued a set 
of HCIs for the human.
3.2.3 Comparison of Isoform Functions and Networks in Mice and Humans—Li 
et al. compared the HCIs between mouse and human to investigate whether they are 
conserved:
1. Choose a set of 306 multi-isoform homologous genes between mouse and 
human. For each of these genes, denote its mouse and human HCI as HCIm and 
HCIh.
2. Identify 61 of the 306 genes whose HCIm and HCIh are homologs based on the 
HomoloGene database in NCBI (http:// ncbi.nlm.nih.gov/homologene).
3. Computationally generate a null distribution of the number of genes whose HCIm 
and HCIh are homologs by chance (41 ± 6).
4. Calculate a p-value by comparing the observed value [61] to the null distribution.
The overlap between mouse and human HCI is significant (p = 0.0003), providing additional 
evidence supporting the “canonical” features of HCIs. As an example, NUDFB6 is a gene 
encoding two splice isoforms: HCI (NM_002493.4, NDUFB6_2) and NCI (NM_182739.2, 
NDUFB6_1); their networks are shown in Fig. 6. The HCI, but not the NCI, was reported to 
be expressed at the protein level in normal human retina [60], further supporting the 
“canonical” characteristics of HCIs.
3.2.4 Examples from the ERBB2 Amplicon and Pathways—The ERBB2 (HER2) 
gene is an epidermal growth factor (EGF) receptor of the receptor tyrosine kinase family. 
The protein encoded by this gene functions by forming a heterodimer through binding with 
ERBB1, ERBB3, or ERBB4 receptor proteins. Amplification or overexpression of this gene 
has been shown to be strongly associated with a major subset of human breast cancers. One 
can explore the isoform functions and networks for this gene:
1. Isoform functions. From the IsoFunc database (http://
guanlab.ccmb.med.umich.edu/isofunc/), identify the functions of the five protein-
coding splice isoforms of ERBB2 based on Ensembl annotation (version 74). For 
example, ENST0000\0541774 was predicted to carry the “canonical Wnt 
signaling pathway” with a fold change = 37. In contrast, the likelihood for the 
other isoforms to have this function is much smaller (fold change ranging from 
1.7 to 3.3). ENST00000445658, ENST00000269571, ENST00000584601, and 
ENST00000406381 are predicted to most likely function in “sterol biosynthetic 
process,” “extracellular matrix disassembly,” “extracellular matrix disassembly,” 
and “cell-substrate junction assembly,” respectively. These predictions suggest 
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the potential functional differences between isoforms, though they need to be 
experimentally validated.
2. Isoform networks. To explore further the functional interactions, obtain the 
isoform networks of ERBB2 isoforms from http://guanlab.ccmb.med.umich.edu/
hisonet/. This server provides networks for two isoforms, 
NM_004448.2(ENST00000269571) and 
NM_001005862.1(ENST00000584601), which are shown in Fig. 7. Both 
networks are enriched for GO biological processes such as “phosphoinositide 3-
kinase cascade” and “protein amino acid autophosphorylation,” suggesting their 
functional similarities. Functional differences were also predicted. For instance, 
GO term “regulation of MAP kinase activity” was enriched in the network of 
NM_004448.2 but not NM_001005862.1, suggesting possible different roles/
extent for ERBB2 isoforms to be involved in the MAP kinase signaling pathway.
3.3 Concluding Remark
The combination of proteomics and transcriptomics with the bio-informatics algorithms and 
methods of structural biology and functional relationship networks can generate many new 
insights and provide testable hypotheses for experimental studies.
4 Notes
There are a variety of computational tools that have been developed in the field, including, 
e.g., Rosetta [62], HHsearch [63], and Modeller [64] for protein structure prediction and 
Concavity [48], FINDSITE [47], and ProFunc [65] for structure-based function annotations. 
While the I-TASSER family tools represent one of the most efficient sets of methods as 
demonstrated in various community-wide structure and functional modeling experiments 
[29, 34, 46, 66], it is important to remember that the results are predictions from automated 
computational programs. The accuracy and confidence of the models vary among different 
proteins, depending on the availability of homologous templates and size of the target 
sequences. We have developed two confidence scores to guide their use by biologist users.
First, C-score [27] is a measurement of confidence of protein structure models built by I-
TASSER [11] and QUARK [12] programs. It was defined based on the significance score of 
structure templates identified by threading alignments and the structural density of Monte 
Carlo-based conformational search. A large-scale benchmark experiment based on 500 
nonredundant proteins showed that there is a high correlation between the C-score and TM-
score of the predicted models, with a Pearson correlation coefficient = 0.91 [27].
Second, we proposed an F-score [38] to estimate the accuracy of structure-based function 
predictions by COFACTOR [37] and COACH [39]. The F-score was defined based on the C-
score of protein structure predictions and the structural and sequence similarities between 
the target and template proteins. A positive correlation between F-score and the accuracy of 
the predicted models was found in both COFACTOR and COACH predictions.
The I-TASSER family tools have been designed to predict protein structure and functions 
from the primary sequences. However, information from experimental data or human-based 
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functional analyses can be of critical importance to improve the accuracy of the modeling. 
The on-line servers and downloadable packages of the I-TASSER family tools have provided 
entries that allow users to conveniently introduce experimental constraints, including contact 
and distance maps and specific template alignments, to the modeling systems.
There are multiple factors that would affect the prediction of functions and networks and 
thus subsequent comparisons, such as choice of gene annotation software for estimating 
isoform expression. For example, the predictions of human isoform functions [57] and 
networks [60] are based on RefSeq (version 37.2) and Ensembl (version 74) gene 
annotations, respectively, so preliminary interpretation of comparative results should be 
viewed with caution. RefSeq annotation is of high quality but is much less complete 
compared to Ensembl, which contains many more (predicted) genes and isoforms. This 
annotation difference will affect the estimation of splice isoform expression and the 
subsequent prediction of functions and networks. Also, note that Hisonet provides functions 
based on GO enrichment, which is different from the directly predicted isoform functions in 
IsoFunc.
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Fig. 1. 
Flowcharts of template-based structure prediction by I-TASSER (a) and ab initio structural 
folding by QUARK (b)
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Fig. 2. 
Protocol of COACH for structure-based protein function annotation. Prediction results from 
five different programs are combined using support vector machine to increase accuracy and 
coverage of function annotations
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Fig. 3. 
The I-TASSER models for two splice isoforms of Annexin 6. (a) The “TPS” residues in 
anxa6-001 are exposed to solvent which helps increase the likelihood of phosphorylation as 
a post-translational modification. The hydroxyl groups, which are the target of kinases for 
phosphorylation, are highlighted in the inset. (b) Due to the absence of “VAAEIL” residues 
(aa 525–530 in anxa6-001) in the anxa6-002 variant, the “TPS” residues are either partially 
or completely buried by other atoms which significantly reduce the possibility of the protein 
for phosphorylation [Modified from reference [1]]
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Fig. 4. 
The schematic of iterative multiple-instance learning (MIL) for isoform-level function 
prediction
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Fig. 5. 
An example query of Anxa6 gene from the mouse isoform function database
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Fig. 6. 
The functional networks of the highest connected isoform (HCI) (NM_002493.4, 
NDUFB6_2) and non- highest connected isoform (NCI) (NM_182739.2, NDUFB6_1) of the 
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6 (NDUFB6) gene
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Fig. 7. 
Isoform networks of ERBB2_1 (NM_004448.2) and ERBB2_2 (NM_001005862) of the 
human ERBB2 gene
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